Tim Watts, CEO of Shield Therapeutics provides an update on its plans to commercialise Accrufer® in the USA

Episode 96,   Dec 10, 2020, 01:52 PM

Headliner
Share
Subscribe
Tim Watts, CEO of Shield Therapeutics #STX provides an update on its plans to commercialise Accrufer® in the USA and talks about their cash position.
Share
Subscribe
Next
Tony Swiericzuk, CEO of SO4 explains how their equity placing enables the financial close on their debt facility
Top episodes
Is a house price crash coming?
by The Vox Markets Podcast
Alastair Smith of Avacta: Successful Completion of Fourth Dose Escalation in AVA6000 Study
by The Vox Markets Podcast
Vox Markets Interview with Avacta CEO Alastair Smith
by The Vox Markets Podcast
Related episodes
The AIM All Share Hit’s an 11 Month High
by The SharePickers Podcast with Justin Waite
Bad News Equals Good News
by The SharePickers Podcast with Justin Waite
Government Borrowing: 2nd highest October figure since monthly records began & it will get worse
by The SharePickers Podcast with Justin Waite